Fig. 2From: Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinomaClinical significance of malignant score and benign score. A, C The distribution of tumor score or benign score in HCC, LC patients, and healthy individuals. B, D The distribution of tumor score or benign score in BCLC (0-D) stage. E, F The distribution of tumor score or benign score in Child-Pugh score (A–C)Back to article page